INDIRECT COMPARISON OF ADALIMUMAB AND VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE IN THE UNITED KINGDOM: COST PER RESPONDER/REMITTER ANALYSIS

Yifei Liu  1     William Reichmann  2     Song Wang  3     Dendy Macaulay  2     Martha Skup  3     Jingdong Chao  3     Yanjun Bao  3    
1 University Of Missouri–kansas City, Kansas City, United States
2 Analysis Group, Inc., Boston, United States
3 Abbvie Inc., North Chicago, United States

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing